LONGENECKER JOHN P PHD 4
4 · Pacira BioSciences, Inc. · Filed Mar 7, 2022
Insider Transaction Report
Form 4
LONGENECKER JOHN P PHD
Director
Transactions
- Sale
Common Stock
2022-03-03$71.73/sh−7,000$502,145→ 18,823 total - Exercise/Conversion
Common Stock
2022-03-03$10.81/sh+7,000$75,670→ 25,823 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-03−7,000→ 0 totalExercise: $10.81Exp: 2022-06-04→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 5, 2012.